Your browser doesn't support javascript.
loading
Ozone treatment effectively eliminates SARS-CoV-2 from infected face masks.
Córdoba-Lanús, Elizabeth; García-Pérez, Omar; Rodríguez-Esparragón, Francisco; Bethencourt-Estrella, Carlos J; Torres-Mata, Laura B; Blanco, Angeles; Villar, Jesús; Sanz, Oscar; Díaz, Juan J; Martín-Barrasa, José L; Serrano-Aguilar, Pedro; Piñero, José-Enrique; Clavo, Bernardino; Lorenzo-Morales, Jacob.
Afiliação
  • Córdoba-Lanús E; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain.
  • García-Pérez O; Departamento de Medicina Interna Dermatología y Psiquiatría Universidad de La Laguna, La Laguna, Tenerife, Spain.
  • Rodríguez-Esparragón F; Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos III, Madrid, Spain.
  • Bethencourt-Estrella CJ; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Torres-Mata LB; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain.
  • Blanco A; Departamento de Medicina Interna Dermatología y Psiquiatría Universidad de La Laguna, La Laguna, Tenerife, Spain.
  • Villar J; Red Cooperativa de Enfermedades Tropicales (RICET), Instituto de Salud Carlos III, Madrid, Spain.
  • Sanz O; CIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
  • Díaz JJ; Research Unit Hospital Universitario Dr Negrín, Instituto de Investigación Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain.
  • Martín-Barrasa JL; Fundación Canaria del Instituto de Investigación Sanitaria de Canarias (FIISC), Las Palmas de Gran Canaria Spain.
  • Serrano-Aguilar P; Instituto Universitario de Enfermedades Tropicales y Salud Pública de Canarias de la Universidad de La Laguna, La Laguna, Tenerife, Spain.
  • Piñero JE; Departamento de Obstetricia, Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología, Universidad de La Laguna La Laguna, Tenerife, Spain.
  • Clavo B; Research Unit Hospital Universitario Dr Negrín, Instituto de Investigación Sanitaria de Canarias (IISC), Las Palmas de Gran Canaria, Spain.
  • Lorenzo-Morales J; Instituto Universitario de Investigaciones Biomédicas y Sanitarias (IUIBS), BioPharm Group Universidad de Las Palmas de Gran Canaria, Spain.
PLoS One ; 17(7): e0271826, 2022.
Article em En | MEDLINE | ID: mdl-35867641
ABSTRACT
The current COVID-19 pandemic is causing profound health, economic, and social problems worldwide. The global shortage of medical and personal protective equipment (PPE) in specialized centers during the outbreak demonstrated the need for efficient methods to disinfect and recycle them in times of emergency. We have previously described that high ozone concentrations destroyed viral RNA in an inactivated SARS-CoV-2 strain within a few minutes. However, the efficient ozone dosages for active SARS-CoV-2 are still unknown. The present study aimed to evaluate the systematic effects of ozone exposure on face masks from hospitalized patients infected with SARS-CoV-2. Face masks from COVID-19 patients were collected and treated with a clinical ozone generator at high ozone concentrations in small volumes for short periods. The study focused on SARS-CoV-2 gene detection (assessed by real-time quantitative polymerase chain reaction (RT-qPCR)) and on the virus inactivation by in vitro studies. We assessed the effects of different high ozone concentrations and exposure times on decontamination efficiency. We showed that high ozone concentrations (10,000, 2,000, and 4,000 ppm) and short exposure times (10, 10, and 2 minutes, respectively), inactivated both the original strain and the B.1.1.7 strain of SARS-CoV-2 from 24 contaminated face masks from COVID-19 patients. The validation results showed that the best condition for SARS-CoV-2 inactivation was a treatment of 4,000 ppm of ozone for 2 minutes. Further studies are in progress to advance the potential applications of these findings.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ozônio / COVID-19 Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ozônio / COVID-19 Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Espanha